Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Takeda (Italy)
h-index: 16
Total citations: 1,324
Total papers: 69
Homepage:
http://www.takeda.it/
Recent papers from Takeda (Italy)
Cost implications of reproductive outcomes in adult patients with advanced Hodgkin lymphoma in the European Union: evaluated from the Danish and Italian healthcare and societal perspectives
Journal of Comparative Effectiveness Research · 2026
Cost Per Remission of Vedolizumab Versus Risankizumab for the Treatment of Moderately to Severely Active Crohn’s Disease in Italy
Advances in Therapy · 2026
Cost minimization analysis of subcutaneous and intravenous immunoglobulin treatment in Italy
Global & Regional Health Technology Assessment · 2026
Psychometric validation of the quality of life Inventory − Disability (QI-Disability) among patients with Lennox-Gastaut syndrome and Dravet syndrome
Epilepsy & Behavior · 2025
Cost-effectiveness of Brentuximab Vedotin plus chemotherapy as frontline treatment of systemic anaplastic large cell lymphoma in Italy
Global & Regional Health Technology Assessment · 2025
Cost-effectiveness of brentuximab vedotin plus chemotherapy as frontline treatment of stage IV Hodgkin lymphoma in Italy
Global & Regional Health Technology Assessment · 2024
Depersonalization/derealization and its relationship to mood and anxiety disorders in the National Comorbidity Survey-Replication (NCS-R)
2024
Cost-Effectiveness of Vedolizumab as a First-Line Advanced Therapy Versus Adalimumab Treatment Sequences for Ulcerative Colitis in Italy
PharmacoEconomics - Open · 2024
Standards of Care for Medical Management of Acromegaly in Pituitary Tumor Centers of Excellence (PTCOE)
2024
The Same but Not the Same: The Case of (S)-Naproxen/cis-1-Amino-2-indanol Chiral Resolution via Diastereomeric Salt Formation
Crystal Growth & Design · 2024
[Cost-Effectiveness Analysis of Maribavir in Patients with Post-Transplant Cytomegalovirus Infection or Disease that are Refractory or Resistant to Conventional Therapy]
Farmeconomia Health economics and therapeutic pathways · 2023
Lung Structure and Risk of Sleep Apnea in SPIROMICS
Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · 2023
Brentuximab vedotin + AVD in cHL: cost impact on adverse events, toxicity, second malignancies, end-of-life and subsequent lines of therapy in Italy
AboutOpen · 2023
Lung Cancer Screening in Asia: An Expert Consensus Report
Journal of Thoracic Oncology · 2023
Cost-minimization analysis of HYQVIA® in the treatment of primary immunodeficiency disease (PID) and secondary immunodeficiency disease (SID) in Italy
AboutOpen · 2023
Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthma
Annals of Allergy Asthma & Immunology · 2023
Association of a Remote Patient Monitoring (RPM) Program With Reduced Hospitalizations in Cancer Patients With COVID-19
JCO Oncology Practice · 2021
Vol-PACT: A Foundation for the NIH Public-Private Partnership That Supports Sharing of Clinical Trial Data for the Development of Improved Imaging Biomarkers in Oncology
JCO Clinical Cancer Informatics · 2018
Early Positron Emission Tomography Response–Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial
Journal of Clinical Oncology · 2017
Melanoma and immunotherapy bridge 2015
Journal of Translational Medicine · 2016